4//SEC Filing
TZIANABOS ARTHUR 4
Accession 0001415889-24-015965
CIK 0001623526other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:19 PM ET
Size
12.6 KB
Accession
0001415889-24-015965
Insider Transaction Report
Form 4
TZIANABOS ARTHUR
DirectorInterim Executive Chair
Transactions
- Award
Director Stock Option (Right to Buy)
2024-06-05+7,639→ 7,639 totalExercise: $16.41Exp: 2034-06-04→ Common Stock (7,639 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of: (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001586226
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:19 PM ET
- Size
- 12.6 KB